Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission

Lars Stelter1, Jen-Chieh Tseng, Armen Torosjan

  • 1Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, USA. lars.stelter@charite.de

Abstract

Insights

Sindbis virus (SINV) shows promise for cancer therapy by targeting tumor cells. However, infection rates vary, indicating factors beyond laminin receptor expression influence efficacy.

Area of Science:

  • Oncolytic virotherapy
  • Molecular imaging
  • Cancer biology

Background:

  • Sindbis virus (SINV) vectors offer targeted delivery of suicide genes to tumor cells for cancer therapy.
  • Monitoring viral load and gene expression is crucial for enhancing SINV-based treatments.

Purpose of the Study:

  • To investigate the role of the 67-kDa laminin receptor (LR) in Sindbis virus tumor cell specificity.
  • To evaluate SINV infection rates in various cancer cell lines using molecular imaging techniques.

Main Methods:

  • Assessed LR expression across different cancer cell lines.
  • Employed bioluminescence, fluorescence molecular tomography, and positron emission tomography for in vitro and in vivo imaging.
  • Quantified SINV infection rates in relation to LR expression.

Main Results:

  • All tested cancer cell lines demonstrated significant LR expression.
  • SINV infection rates varied considerably among cell lines, independent of LR levels.

Conclusions:

  • Molecular imaging confirmed vector delivery to neoplastic cells.
  • Cellular LR expression alone does not solely determine SINV infection rates.
  • Further research is needed to elucidate mechanisms of SINV cellular infection and replication.

Related Concept Videos